ArticleHaematologica2024
The role of the mineralocorticoid receptor in steroidinduced cytotoxicity in pediatric acute lymphoblastic leukemia.
Annelienke M Van Hulst, Jordy C G Van der Zwet, Jessica G C A M Buijs-Gladdines, Willem K Smits, Marta Fiocco, Rob Pieters, Frank N Van Leeuwen, Marry M Van den Heuvel-Eibrink, Erica L T Van den Akker, Jules P P Meijerink
Open access · goldAbstract readLetter
In one paragraphArticle in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors at 4 institutions in 2 countries.
Annelienke M Van HulstPrincess Maxima Center for Pediatric Oncology, Utrecht. a.vanhulst@prinsesmaximacentrum.nl.
Jordy C G Van der ZwetPrincess Maxima Center for Pediatric Oncology, Utrecht.
Jessica G C A M Buijs-GladdinesPrincess Maxima Center for Pediatric Oncology, Utrecht.
Willem K SmitsPrincess Maxima Center for Pediatric Oncology, Utrecht.
Marta FioccoPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Mathematical Institute, Leiden University, Leiden, The Netherlands; Department of Biomedical data Science, Medical Statistics, Leiden University Medical Centre.
Rob PietersPrincess Maxima Center for Pediatric Oncology, Utrecht.
Frank N Van LeeuwenPrincess Maxima Center for Pediatric Oncology, Utrecht.
Marry M Van den Heuvel-EibrinkPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Child Health, UMCU-Wilhelmina Children's Hospital, Utrecht. m.m.vandenheuvel-eibrink@prinsesmaximacentrum.nl.
Erica L T Van den AkkerPediatric Endocrinology, Erasmus MC- Sophia Children's Hospital, Rotterdam.
Jules P P MeijerinkPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands; Presently working at Acerta-Pharma (AstraZeneca), Oss.
Princess Máxima Center · NLAstraZeneca (Poland) · PLErasmus MC - Sophia Children’s Hospital · NLWilhelmina Children's Hospital · NL
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Precursor Cell Lymphoblastic Leukemia-LymphomaReceptors, MineralocorticoidChildChild, PreschoolHumansReceptors, Mineralocorticoid
Identifiers
PMID38205521
PMCPMC11063837
OpenAlexW4390741812
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390